PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -28.6% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7 | -22.2% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9 | -43.8% | 4,600 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $16 | -99.6% | 4,600 | -20.7% | 0.00% | – |
| Q3 2022 | $4,000 | -20.0% | 5,800 | -37.5% | 0.00% | – |
| Q2 2022 | $5,000 | -82.8% | 9,276 | -70.2% | 0.00% | -100.0% |
| Q1 2022 | $29,000 | -61.8% | 31,176 | +171.9% | 0.00% | -33.3% |
| Q4 2021 | $76,000 | -29.6% | 11,466 | -38.7% | 0.00% | -40.0% |
| Q3 2021 | $108,000 | +140.0% | 18,700 | +156.2% | 0.01% | +150.0% |
| Q2 2021 | $45,000 | +25.0% | 7,300 | -57.3% | 0.00% | +100.0% |
| Q1 2021 | $36,000 | +800.0% | 17,100 | +402.9% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 3,400 | +240.0% | 0.00% | – |
| Q3 2020 | $3,000 | -94.9% | 1,000 | -93.1% | 0.00% | -100.0% |
| Q2 2020 | $59,000 | +90.3% | 14,500 | +57.6% | 0.00% | +100.0% |
| Q1 2020 | $31,000 | +1450.0% | 9,200 | +411.1% | 0.00% | – |
| Q4 2019 | $2,000 | – | 1,800 | +800.0% | 0.00% | – |
| Q4 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |